Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Vassilopoulos

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Internal Medicine|November 15, 2011
Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? YesDimitrios Vassilopoulos
Nature Clinical Practice. Rheumatology|August 9, 2007
Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLEDimitrios Vassilopoulos
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Immunization in patients with inflammatory rheumatic diseasesKonstantinos Thomas, Dimitrios Vassilopoulos
Annals of the New York Academy of Sciences|December 29, 2006
Dialogue between the brain and the immune system in inflammatory arthritisDimitrios Vassilopoulos, Dimosthenis Mantzoukis
Mediterranean Journal of Rheumatology|July 18, 2020
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic TherapiesKonstantinos Thomas, Dimitrios Vassilopoulos
Current Opinion in Rheumatology|September 24, 2016
Infections and vasculitisKonstantinos Thomas, Dimitrios Vassilopoulos
Current Opinion in Rheumatology|October 30, 2009
Rheumatic manifestations of hepatitisDimitrios Vassilopoulos, Spilios Manolakopoulos
Seminars in Arthritis and Rheumatism|June 7, 2011
Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?Sophie Mavrogeni, Dimitrios Vassilopoulos
Arthritis and Rheumatism|March 29, 2002
Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapiesDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|October 6, 2007
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infectionsDimitrios Vassilopoulos, Leonard H Calabrese
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Internal Medicine|November 15, 2011
Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? YesDimitrios Vassilopoulos
Nature Clinical Practice. Rheumatology|August 9, 2007
Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLEDimitrios Vassilopoulos
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Immunization in patients with inflammatory rheumatic diseasesKonstantinos Thomas, Dimitrios Vassilopoulos
Annals of the New York Academy of Sciences|December 29, 2006
Dialogue between the brain and the immune system in inflammatory arthritisDimitrios Vassilopoulos, Dimosthenis Mantzoukis
Mediterranean Journal of Rheumatology|July 18, 2020
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic TherapiesKonstantinos Thomas, Dimitrios Vassilopoulos
Current Opinion in Rheumatology|September 24, 2016
Infections and vasculitisKonstantinos Thomas, Dimitrios Vassilopoulos
Current Opinion in Rheumatology|October 30, 2009
Rheumatic manifestations of hepatitisDimitrios Vassilopoulos, Spilios Manolakopoulos
Seminars in Arthritis and Rheumatism|June 7, 2011
Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?Sophie Mavrogeni, Dimitrios Vassilopoulos
Arthritis and Rheumatism|March 29, 2002
Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapiesDimitrios Vassilopoulos, Leonard H Calabrese
Current Opinion in Rheumatology|October 6, 2007
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infectionsDimitrios Vassilopoulos, Leonard H Calabrese
Pageof 20